<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02777606</url>
  </required_header>
  <id_info>
    <org_study_id>2014A020212280</org_study_id>
    <nct_id>NCT02777606</nct_id>
  </id_info>
  <brief_title>The Efficacy of Si-Ni-Tang (a Chinese Herbal Formula) for Severe Sepsis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong Provincial Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Provincial Hospital of Traditional Chinese Medicine</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of Si-Ni-Tang (a Chinese Herbal Formula
      documented in Shang Han Lun) in treating severe sepsis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>28-day all-cause mortality rates</measure>
    <time_frame>28 days after enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Human leukocyte antigen DR (HLA-DR) expression on cluster of differentiation (CD) 14 T lymphocytes</measure>
    <time_frame>day 0, 3 and 7 after enrollment</time_frame>
    <description>HLA-DR expression on cluster of differentiation (CD) 14 T lymphocytes measured on day 0, 3 and 7 after enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD 4+/ CD 8+ ratio</measure>
    <time_frame>day 0, 3 and 7 after enrollment</time_frame>
    <description>CD 4+/ CD 8+ ratio measured on day 0, 3 and 7 after enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procalcitonin (PCT)</measure>
    <time_frame>day 0, 3 and 7 after enrollment</time_frame>
    <description>PCT measured on day 0, 3 and 7 after enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sequential Organ Failure Assessment (SOFA) score</measure>
    <time_frame>day 0, 3 and 7 after enrollment</time_frame>
    <description>SOFA score measured on day 0, 3 and 7 after enrollment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Si-Ni-Tang (a Chinese Herbal Formula)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment for severe sepsis adheres to the International guidelines for management of sepsis and septic shock 2012 and the Surviving Sepsis Campaign updated bundles in response to new evidence in 2015. Besides, 150ml of Si-Ni-Tang will be given by p.o. or a nasogastric tube once per day for 3-5 days in the treatment group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Treatment for severe sepsis adheres to the International guidelines for management of sepsis and septic shock 2012 and the Surviving Sepsis Campaign updated bundles in response to new evidence in 2015.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Si-Ni-Tang</intervention_name>
    <description>Treatment adheres to the International guidelines for management of severe sepsis and septic shock( 2012) and the Surviving Sepsis Campaign updated bundles in response to new evidence in 2015 for both the treatment group and the control group. In addition, 150ml of Si-Ni-Tang will be given by p.o. or by a nasogastric tube once a day for 3-5 days in the treatment group.</description>
    <arm_group_label>Si-Ni-Tang (a Chinese Herbal Formula)</arm_group_label>
    <other_name>Sini decoction</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe sepsis (according to American college of chest Physicians/ Society of Critical
             Care Medicine (ACCP/SCCM) criteria)

          -  Informed consent provided by patients or legally authorized representative

          -  Yin syndrome in syndrome differentiation (according to principles of traditional
             Chinese medicine (TCM) syndrome differentiation)

        Exclusion Criteria:

          -  Pregnant or nursing female

          -  Subject receiving immunosuppressive or immunoenhancement therapy in the past 3 months

          -  Patients with known or suspicious autoimmune diseases

          -  Patients not expected to survive 28 days due to end-stage disease or other
             uncorrectable medical condition

          -  Fasting subjects

          -  Known or suspicious allergy to any ingredient of Si-Ni-Tang

          -  Patients not expected to survive 5 days for various reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fang Lai, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Provincial Hospital of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yun Han, Doctor</last_name>
    <phone>8613802530960</phone>
    <email>hy660960@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rui-feng Zeng, Master</last_name>
    <phone>8618520288411</phone>
    <email>13760872664@139.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong Provincial Hospital of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510145</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fang Lai, Master</last_name>
      <phone>8613560470029</phone>
      <email>13016090@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Rui-feng Zeng, Master</last_name>
      <phone>8618520288411</phone>
      <email>13760872664@139.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2016</study_first_submitted>
  <study_first_submitted_qc>May 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2016</study_first_posted>
  <last_update_submitted>July 29, 2017</last_update_submitted>
  <last_update_submitted_qc>July 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong Provincial Hospital of Traditional Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Lai Fang</investigator_full_name>
    <investigator_title>Attending Doctor</investigator_title>
  </responsible_party>
  <keyword>Severe Sepsis</keyword>
  <keyword>Sini Decoction</keyword>
  <keyword>Immune Function</keyword>
  <keyword>Mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

